机译:类风湿关节炎合并依那西普治疗的布氏肺孢子虫肺炎:15例回顾性分析及危险因素分析
Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan;
Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan;
Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan;
Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan;
Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan;
Department of Diagnostic Radiology, International Medical Center, Saitama Medical Uni;
Pneumocystis jirovecii pneumonia; Rheumatoid arthritis; Etanercept; Anti-TNF therapy; Opportunistic infection;
机译:类风湿关节炎患者联合依那西普治疗的吉氏肺孢子虫肺炎:15例回顾性分析及危险因素分析
机译:阿达木单抗治疗的类风湿关节炎肺炎支原体肺炎的临床特征和危险因素:17例回顾性研究与病例对照研究
机译:用肿瘤坏死因子a抑制剂治疗的类风湿关节炎患者患上罗氏肺孢子菌肺炎的风险:英国风湿病学会生物制剂协会的结果
机译:依赖替辛醚治疗少年类风湿性关节炎中AA淀粉样液 - 初步体验
机译:柳氮磺胺吡啶对类风湿关节炎肺炎克氏杆菌的预防作用的临床研究
机译:类风湿关节炎患者的肺炎支原体肺炎:风险和预防建议
机译:根据一项回顾性研究发现的危险因素,对使用生物制剂治疗的类风湿性关节炎患者预防肺囊虫性肺炎